454 Life Sciences - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
MarketLine, January 2013, Pages: 65
Project Synopsis:
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
' 454 Life Sciences Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by 454 Life Sciences since January 2007.
Scope:
– Provides intelligence on 454 Life Sciences's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by 454 Life Sciences and its subsidiaries since 2007.
– Information about key financial and legal advisors for 454 Life Sciences's financial deals transactions.
– Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity.
Highlights:
This report includes 454 Life Sciences's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by 454 Life Sciences. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
– Form an independent opinion about 454 Life Sciences’s growth strategies through the organic and inorganic activities undertaken since 2007.
– Track your competitors’ business structure and growth strategies.
COMPANY OVERVIEW AND KEY FACTS
PARTNERSHIP
--Partnership – Overview
--Partnership – Deal reports
--Private Equity and Ownership – Deal reports
APPENDIX
--About Datamonitor Financial Deals Database
--Deal Definition and Methodology
--About Datamonitor
--Datamonitor Professional Services Knowledge Center
LIST OF TABLES
--454 Life Sciences activity by deal type – volume (2011-TTM2012)
--454 Life Sciences activity by deal type – volume (2008 -YTD2012)
--454 Life Sciences legal advisor ranking by value ($m)
--454 Life Sciences targets and partners (2008 -YTD2012)
--454 Life Sciences partnership volume and value trend (2008-YTD2012)
--454 Life Sciences partnership trend by key deal type (2008-YTD2012)
LIST OF FIGURES
--454 Life Sciences activity by deal type - volume (trailing twelve months (TTM))
--454 Life Sciences activity by deal type - volume (2008-YTD2012)
--454 Life Sciences partnership volume and value trend (2008-YTD2012)
--454 Life Sciences partnership trend by key deal type (2008-YTD2012)
454 Life Sciences
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
